Institute of Biomedicine - UTU Research Portal - UTU Research Portal

Go to Header Go to Navigation Go to Content Go to Footer

Institute of Biomedicine

University of Turku » Faculty of Medicine

Go to first page

Go to previous page

1 of 31

Go to next page

Go to last page

Go to first page

Go to previous page

386 of 521

Go to next page

Go to last page

Progressive dopaminergic defect in a patient with primary progressive multiple sclerosis (2019)
Prolaktiini (2024)
Prolaktiini (2019)
Proliferation-associated miRNAs-494, -205, -21 and -126 detected by in situ hybridization: expression and prognostic potential in breast carcinoma patients (2018)
Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy (2024)
Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells (2011)
Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells (2020)
Prolyl oligopeptidase inhibition reduces alpha-synuclein aggregation in a cellular model of multiple system atrophy (2021)
Prolyl oligopeptidase inhibition reduces oxidative stress via reducing NADPH oxidase activity by activating protein phosphatase 2A (2021)
Prolyl Oligopeptidase Regulates Dopamine Transporter Oligomerization and Phosphorylation in a PKC- and ERK-Independent Manner (2021)